Dexrazoxane Hydrochloride and Insulin glulisine Subcutaneous
Determining the interaction of Dexrazoxane Hydrochloride and Insulin glulisine Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Hydrochloride-Insulin human inhaled Inhalation
- Dexrazoxane Hydrochloride-Insulin human regular Injection
- Dexrazoxane Hydrochloride-Insulin inhalation
- Dexrazoxane Hydrochloride-Insulin isophane
- Dexrazoxane Hydrochloride-Insulin isophane and insulin regular
- Dexrazoxane Hydrochloride-Insulin lispro
- Insulin glulisine Subcutaneous-Dexrazoxane Intravenous
- Insulin glulisine Subcutaneous-Dextenza Insert
- Insulin glulisine Subcutaneous-Dextenza intraocular
- Insulin glulisine Subcutaneous-Dextran 40
- Insulin glulisine Subcutaneous-Dextran 70 6% in 5% Dextrose high molecular weight
- Insulin glulisine Subcutaneous-Dextran 75